Allspring Global Investments
OTLK icon

Allspring Global Investments’s Outlook Therapeutics OTLK Stock Holding History

Allspring Global Investments’s Portfolio OTLK Stock Details OTLK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-517
Closed -$2.28K – 2589
2023
Q3 		$2.28K Buy
+517
New +$11.4K ﹤0.01% 2708

Other funds holding OTLK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Allspring Global Investments's OTLK Position: Q4 2023 in Review

Allspring Global Investments sold out of Outlook Therapeutics (OTLK) in Q4 2023, closing a stake of 517 shares — an estimated $2.28K sold.

Allspring Global Investments first reported a position in OTLK in Q3 2023 and held it in 1 quarter. The position peaked at $2.28K in Q3 2023. 87 funds tracked by Wall St. Rank hold OTLK as of Q4 2023.

  • Allspring Global Investments reported no remaining Outlook Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 517 Outlook Therapeutics shares in Q4 2023, an estimated $2.28K.
  • Allspring Global Investments first reported a position in Outlook Therapeutics in Q3 2023 and held it in 1 quarter.
  • Allspring Global Investments's Outlook Therapeutics position peaked at $2.28K in Q3 2023.
  • 87 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.